1246
S. Krompiec et al.
1-(1-tert-Butoxypropoxy)butane (9, C11H24O2)
4.47 (t, J = 4.8 Hz), 4.75 (dq, J = 12.6 Hz, J = 6.7 Hz,
1H), 6.22 (dq, J = 12.6 Hz, J = 1.6 Hz, 1H) ppm; 13C
NMR (100 MHz, CDCl3): d = 9.2, 12.5, 13.9, 19.2, 26.3,
31.5, 65.5, 68.5, 71.3, 98.2, 104.4, 146.7 ppm;
(Z)-isomer 1H NMR (400 MHz, CDCl3): d = 0.89–0.93
(m, 3H), 0.97 (t, J = 7.5 Hz), 1.35–1.45 (m, 4H), 1.58 (dd,
J = 6.7 Hz, J = 1.7 Hz, 3H), 1.64–1,71 (m, 2H), 3.72 (t,
J = 6.6 Hz, 2H), 3.83–3.87 (m, 2H), 3.95–3.98 (m, 2H),
4.36 (dq, J = 6.2 Hz, J = 6.7 Hz, 1H), 4.82 (t,
J = 4.6 Hz), 5.94 (dq, J = 6.2 Hz, J = 1.7 Hz, 1H) ppm;
13C NMR (100 MHz, CDCl3): d = 8.0, 12.6, 13.9, 19.1,
27.0, 31.9, 64.9, 68.9, 71.8, 100.7, 105.5, 145.7 ppm;
B.p.: 65 °C (1.73 mbar); 1H NMR (300 MHz, CDCl3):
d = 0.91 (t, J = 7.5 Hz, 3H), 0.93 (t, J = 7.3 Hz, 3H),
1.24 (s, 9H), 1.33–1.45 (m, 2H), 1.51–1.67 (m, 4H), 3.42
(dt, J = 9.4, 6.6 Hz, 1H), 3.58 (dt, J = 9.4, 6.6 Hz, 1H),
4.39 (t, J = 5.8 Hz, 1H) ppm; 13C NMR (75 MHz,
CDCl3): d = 9.1, 13.9, 19.5, 26.5, 28.7, 32.1, 65.2, 74.8,
104.3 ppm.
1-(1-Butoxypropoxy)-3,7-dimethylocta-2,6-diene
(10, C17H32O2)
Colorless oil; 1H NMR (400 MHz, CDCl3): d = 0.81–0.83
(dd, J = 4.0 Hz, J = 2.5 Hz, 3H), 0.91 (t, J = 7.3 Hz,
3H), 1.25–1.29 (m, 2H), 1.36–1.40 (m, 2H), 1.51–1.56 (m,
2H), 1.58 (s, 3H), 1.66 (s, 6H), 1.99–2.12 (m, 4H), 3.55 (t,
J = 6.6 Hz), 4.11 (d, J = 7.9 Hz), 4.43 (t, J = 5.7 Hz),
5.08 (t, J = 6.6 Hz), 5.34 (t, J = 7.9 Hz) ppm; 13C NMR
(100 MHz, CDCl3): d = 9.2, 11.5, 14.0, 14.4, 20.6, 22.7,
27.8, 29.2, 41.5, 62.0, 65.3, 103.7, 121.1, 124.2, 131.6,
139.8 ppm; HRMS (ESI?): calcd for C17H32O2Na
[M ? Na]? 291.2295, found 291.2309.
(E)-10-(1-Butoxypropoxy)dec-2-ene (5, C17H34O2)
1
B.p.: 118 °C (0.39 mbar); H NMR (400 MHz, CDCl3):
d = 0.86–0.97 (m, 9H), 1.23–1.44 (m, 10H), 1.51–1.66 (m,
6H), 1.92–2.04 (m, 2H), 3.37–3.43 (m, 2H), 3.53–3.63 (m,
2H), 4.39 (t, J = 5.7 Hz, 1H), 5.36–5.44 (m, 2H) ppm; 13
C
NMR (100 MHz, CDCl3): d = 9.0, 13.9, 17.8, 19.4, 25.6,
26.3, 26.5, 27.0, 31.6, 31.9, 32.0, 32.6, 65.2, 65.5, 104.3,
124.5, 131.6 ppm.
1-[1-(1-Butoxypropoxy)propoxy]butane (11, C14H30O3)
B.p.: 74 °C (7 mbar); 1H NMR (400 MHz, CDCl3):
d = 0.91 (t, J = 7.4 Hz, 6H), 0.93 (t, J = 7.4 Hz, 6H),
1.34–1.44 (m, 4H), 1.51–1.66 (m, 8H), 3.42 (dt, J = 9.4,
6.6 Hz, 2H), 3.58 (dt, J = 9.4, 6.6 Hz, 2H), 4.39 (t,
J = 5.8 Hz, 2H) ppm; 13C NMR (100 MHz, CDCl3):
d = 8.9, 13.7, 19.3, 26.4, 31.9, 65.0, 104.2 ppm.
(Z)-1-(1-Butoxypropoxy)octadec-9-ene (6, C25H50O2)
1
Colorless oil; H NMR (400 MHz, CDCl3): d = 0.88 (t,
J = 7.1 Hz, 3H), 0.91 (t, J = 7.7 Hz, 3H), 0.92 (t,
J = 7.3 Hz, 3H), 1.26–1.40 (m, 26H), 1.52–1.66 (m, 4H),
1.94–2.05 (m, 4H), 3.37–3.44 (m, 2H), 3.52–3.64 (m, 2H),
4.39 (t, J = 5.7 Hz, 1H), 5.33–5.43 (m, 2H) ppm; 13C
NMR (100 MHz, CDCl3): d = 9.1, 13.9, 14.0, 19.4, 22.7,
25.8, 26.5, 27.17, 29.1, 29.2, 29.43, 29.43, 29.45, 29.6,
29.6, 29.6, 31.8, 32.0, 32.6, 65.2, 65.5, 104.2, 128.1,
128.9 ppm; HRMS (ESI?): calcd for C25H50O2Na
[M ? Na]? 405.3708, found 405.3703.
1-(1,4-Dibutoxybutoxy)decane (12, C22H46O3)
1
Colorless oil; H NMR (400 MHz, CDCl3): d = 0.86-0.95
(m, 9H), 1.27–1.41 (m, 18H), 1.51–1.68 (m, 10H),
3.37–3.44 (m, 6H), 3.54–3.61 (m, 2H), 4.48 (t, 1H,
J = 5.4 Hz) ppm; 13C NMR (100 MHz, CDCl3):
d = 13.8, 13.8, 14.0, 19.4, 22.6, 25.0, 26.2, 29.3, 29.4,
29.5, 29.6, 29.8, 29.8, 30.2, 31.8, 31.8, 31.9, 65.2, 65.5,
70.4, 70.5, 102.9 ppm; HRMS (ESI?): calcd for
C22H46O3Na [M ? Na]? 381.3339, found 381.3349.
[(1-Butoxypropoxy)methyl]benzene (7, C14H22O2)
B.p.: 98 °C (7 mbar); 1H NMR (300 MHz, CDCl3):
d = 0.93 (t, J = 7.3 Hz, 3H), 0.94 (t, J = 7.4 Hz, 3H),
1.34–1.47 (m, 2H), 1.52–1.63 (m, 2H), 1.66–1.75 (m, 2H),
3.46 (dt, J = 9.4, 6.5 Hz, 1H), 3.60 (dt, J = 9.4, 6.5 Hz,
1H), 4.52 (d, J = 11.8 Hz, 1H), 4.53 (t, J = 5.8 Hz, 1H),
4.64 (d, J = 11.8 Hz, 1H), 7.38–7.22 (m, 5H) ppm; 13C
NMR (75 MHz, CDCl3): d = 9.1, 13.9, 19.5, 26.4, 32.0,
65.2, 67.1, 103.8, 127.5, 127.7, 128.4, 138.6 ppm; GC–MS
(70 eV): m/z (%) = 221 (5), 193 (24), 148 (18), 108 (20),
92 (20), 91 (100), 79 (20), 57 (23).
(E)-10-(1,4-Dibutoxybutoxy)dec-2-ene (13, C22H44O3)
Colorless oil; 1H NMR (400 MHz, CDCl3): d = 0.87–0.97
(m, 9H), 1.26–1.42 (m, 12H), 1.52–1.67 (m, 10H),
1.90–2.04 (m, 2H), 3.37–3.43 (m, 6H), 3.54–3.59 (m,
2H), 4.48 (t, J = 5.5 Hz, 1H), 5.37–5.42 (m, 2H) ppm; 13
C
NMR (100 MHz, CDCl3): d = 13.9, 14.0, 17.9, 19.4, 19.5,
25.1, 26.3, 29.2, 29.4, 29.6, 30.0, 30.3, 31.9, 32.1, 32.6,
65.3, 65.6, 70.6, 70.7, 103.1, 124.6, 131.6 ppm.
1-[1-(2,2,2-Trifluoroethoxy)propoxy]butane
(8, C9H17F3O2)
B.p.: 66 °C (27 mbar); 1H NMR (400 MHz, CDCl3):
d = 0.91–0.95 (m, 6H), 1.34–1.44 (m, 2H), 1.52–1.59
(m, 2H), 1.61–1.68 (m, 2H), 3.44 (dt, J = 6.6, 9.4 Hz, 1H),
3.60–3.64 (m, 1H), 3.84 (q, J = 8.8 Hz, 1H), 3.85 (q,
J = 8.8 Hz, 1H), 4.56 (t, J = 5.9 Hz, 1H) ppm; 13C NMR
(100 MHz, CDCl3): d = 8.7, 13.8, 19.3, 26.0, 31.7, 61.4,
65.9, 104.4, 124.2 (q, J = 277.8 Hz) ppm.
Acknowledgments This work was supported by The State Com-
mittee for Scientific Research, Project No. N N204 272237. Mateusz
Penkala is a participant in UPGOW project, co-financed by the
European Union within the European Social Fund.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
123